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Abstract Background: Leiomyosarcoma (LMS) of the colon, rectum, and anus comprise less
than 0.1% of all rectal malignancies with isolated leiomyosarcomas of the anal canal represent-
ing only eight reported cases. We report one more case and a review of the world literature.
Case report: An 80-year-old male presented with a complaint of bright red blood per rectum,
constipation, and a subjective history of a rectal mass diagnosed 3 years prior. Pertinent find-
ings on physical exam included a hard, non-mobile mass in the anus which biopsy showed to be
a LMS. The patient only wished to have a local excision of the mass performed. At the time of
operation the perianal mass extended from the external sphincters into the anal canal. The
mass was excised with clean margins. The patient refused adjuvant therapy. Approximately
7 months later, the patient was found to have a local recurrence. At this time the patient
opted for local excision and radiotherapy.
Conclusion: Isolated LMS of the anus is an extremely rare finding with only eight previous re-
ports in the world literature. LMS is an aggressive tumor with a high local recurrence rate as
well as significant hematogenous spread. Due to its rarity, there is insufficient data regarding
the optimal treatment. Our literature review has displayed some limited preference for radical
surgery over local excision, which may in turn lead to a better outcome.
ª 2007 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.Introduction
Leiomyosarcoma (LMS) of the colon, rectum, and anus
comprise less than 0.1% of all rectal malignancies.1,2 Cancer
of the anal canal comprises only 2% of all colonic malignan-
cies. LMS is a mesenchymal tumor that originates from
smooth muscle cells. Aggressive behavior is usually found
in tumors with greater than 10 mitoses/10 high-powered
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doi:10.1016/j.ijsu.2007.04.012field (hpf). Additionally, necrosis, increased cellularity
with cytological atypia, or size greater than 5 cm in diameter
are all features suggestive of malignancy. It occurs more fre-
quently in women, with the majority of the LMS being in the
uterus and uterine/adnexal ligaments. Some LMS appear to
grow under estrogenic influence, which may explain the
above finding.3 The one exception is the cutaneous variant,
which is seen as frequently, if notmore often, inmales.3 This
tumor can be found at any age but has a particular predilec-
tion in the fifth and sixth decades of life.
Standard staining with hematoxylin and eosin and
trichrome are used to determine the cells of origin, whichhed by Elsevier Ltd. All rights reserved.
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when spindle cells exhibit storiform and pallisading appear-
ance and are grouped in bundles. The nuclei display
pleomorphic characteristics as well as atypia. Additionally,
immunohistochemical staining can elucidate the tumor
type. Cytokeratin, a marker for epithelial tumors, and
vimentin antibodies, which is a non-specific marker of
smooth muscle, can be used. Desmin is used to make the
distinction between well and poorly differentiated tumors
(desmin being present in well differentiated tumors).
Smooth muscle actin (SMA) receptors are normally present
in smooth muscle and vessels, but are a sign of smooth
muscle tumors when the location of the staining is
interdigitated with tissues of other cell lines and in in-
appropriate locations. Staining for S100 receptors is used to
exclude malignant melanoma and neural tumors. In this
test some mild staining can also be normal as this stain can
be taken up in host cells of the immune system.
It is important to note that while all LMS have a common
histologic definition, the biologic action differs depending
on the location of the tumor. It is for this reason that LMS
are broken up into three groups: retroperitoneal and
intraabdominal, cutaneous and subcutaneous variant, as
well as those of vascular origin.3
Leiomyosarcoma of the anus is an even more rare entity
with only eight cases reported in the world literature.1,2,4e8
Given the uncommon nature of this tumor in this location
and the lack of specific data in some of the previously re-
ported cases (i.e., precise location of tumor, specific treat-
ment and adjuvant therapy and follow-up), consensus
about its treatment is surrounded by much controversy.
We can only surmise what may be the most appropriate
treatment based on the management of epithelial tumors
at this site. Therefore, herein we report one more case of
LMS of the anal canal and a review of the world’s literature
in an attempt to provide insight into the most appropriate
treatment for this unusual tumor of the anal canal.
Case report
An 80-year-old Slavic male with a subjective history of
a ‘‘rectalmass’’ diagnosed 3 years prior presentedwith com-
plaint of bright red blood per rectum and constipation for
2 days. There was no history of external hemorrhoids. He
stated that this was the first episode of its kind he had expe-
rienced. He denied any recentweight loss. Both pastmedical
history and past surgical history were non-significant. He had
a 40-pack year history of cigarette smoking, denied alcohol
use and the only medications he was taking on a regular basis
were stool softeners.
On physical exam there was a mass noted on the left,
posteriolateral position in theanal canal; approximately 3 cm
from the anal verge. It was an approximately 10  10 cm
hard, non-mobile perianal mass. Routine abdominal x-rays
were unremarkable except for fecal impaction. The preoper-
ative serum carcinoembrionic antigen level was essentially
normal with a value of 1.5 mg/L. The anoscopic biopsy results
showed features suggestive ofmalignancywhenexaminedvia
hematoxylin and eosin staining (namely, cellular atypia) (see
Fig. 1). Biopsy tissue examined immunohistochemically via
the immunoperoxidase technique was positive for vimentin,smooth muscle actin and rare immunoreactive cells to
desmin. These findings suggested that the tumor was of mes-
enchymal origin, more specifically of smooth muscle. The
relative lack of staining of desmin in this tissue excluded
a well differentiated tumor (see Fig. 2A and B). Tissue was
negative for receptors for cytokeratin, prostatic specific
antigen, prostatic basal cell antigen and leukocyte common
antigen. This excluded epithelial tumors (cytokeratin) and
malignant melanoma.
A CT scan of his abdomen and pelvis with oral and
intravenous (IV) contrast showed a mass in the anus with
no evidence of local invasion or metastasis (see Fig. 3). MRI
of the pelvis showed a large anal mass nearly occluding the
entire anal canal. The T2 weighted MRI displayed that the
mass had a similar density as the surrounding skeletal muscle
(see Fig. 4). Triphase bone scan was negative for evidence of
metastases. The patients’ preoperative work-up displayed
a tumor that was highly suggestive of a leiomyosarcoma.
When offered surgery, the patient refused any radical proce-
dure (abdominoperineal resection) but agreed to local exci-
sion only with no postoperative adjuvant therapy.
Gross operative findings included a perianal, fungating
mass extending into the distal rectum from the anal canal.
Upon further dissection, the tumor was found to arise from
the soft tissues around the anal canal (namely, the external
sphincters) with no mucosal involvement. The surgical pro-
cedure included a transanal excision of the mass with
preservation and primary reconstruction of the perianal
area and sphincters. The excised mass was 6  6  4.5 cm,
dumbbell shaped, and weighed 90 g (see Fig. 5A). Transec-
tion of themass showed that the nodular portions were com-
pletely necrotic with cystic and hemorrhagic changes (see
Fig. 5B). These gross findings were consistent with a high
grade LMS. The features seen on hematoxylin and eosin
staining were consistent withmalignancy. These features in-
cluded plump, pleiomorphic, pallisading, atypical nuclei and
cytoplasmic inclusions. Deep margins were noted to be free
of malignant cells, however the lateral submucosal margins
could not be adequately evaluated. More importantly,
the greater than 10 mitoses/10 hpf was consistent with
Figure 1 Anoscopic biopsy showed features suggestive of
malignancy, namely, cellular atypia (hematoxylin and eosin,
magnification is 40).
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tient’s abdomen and pelvis with oral and intravenous contrast
displayed a mass in the anus. There was no evidence of local
invasion or metastasis.
Figure 2 (A) Biopsy tissue examined immunohistochemically
was positive for smooth muscle actin (SMA). These findings sug-
gested that the tumor was of mesenchymal origin, more specif-
ically of smooth muscle (immunohistochemistry for SMA,
magnification is 40). (B) The relative lack of staining of des-
min in this tissue excluded a well-differentiated tumor (immu-
nohistochemistry for desmin, magnification is 40).a high-grade malignancy (see Fig. 6). The negative cytoker-
atin stain showed that this tumorwas ofmesenchymal origin.
The trichrome as well as the desmin staining were evidence
of the smoothmuscle origin of this tumor. This tumor showed
all the features of malignancy (i.e. large, abnormal, pleio-
morphic nuclei with many mitoses and coarse chromatin
structure). Also apparent was a high nucleus to cytoplasm ra-
tio, another feature pathonomonic for malignancy. The pa-
tient refused adjuvant therapy.
Bimonthly examinations and anoscopy performed the first
6 months after surgery were unremarkable. In the seventh
post-operative month there was noted to be a thickened
area of scar via anoscopic examination. The patient again re-
fused a radical procedure and agreed only to local excision of
the area in question. The excised scar mass showed features
similar to the previously excised tumor with greater than 15
mitoses/10 hpf, characteristic of high-grade smooth muscle
malignancy (demonstrating local recurrence of the LMS) (see
Fig. 7). This tumor was of a higher grade than the originally
excised one as is evidenced by the increased mitotic figures.
The tumor margins were free of malignant cells. At this time
the patient agreed to a course of external beam
radiotherapy.
One month after the repeat excision, a CT scan of the
abdomen and pelvis with oral, rectal, and IV contrast was
performed. It was significant only for prostatism, with no
Figure 4 Image showing sagittal view of a T2 weighted MRI of
the patients pelvis showed a large mass in the anus nearly oc-
cluding the entire anal canal. On the T2 weighted image, it had
a similar density as the surrounding the skeletal muscle. This
was consistent with a leiomyosarcoma.
348 N.M. Rowe et al.Figure 6 The histology of the resected specimen displayed
plump, pleiomorphic, pallisading, atypical nuclei and cytoplas-
mic inclusions. There was greater than 10 mitoses/10 hpf was
consistent with a high-grade malignancy (hematoxylin and
eosin, magnification is 10).
Figure 5 (A) The excised anal mass was 6  6  4.5 cm,
dumbbell shaped, and weighed 90 g. (B) Transection of the
mass showed that the nodular portions were completely ne-
crotic with cystic and hemorrhagic changes.evidence of masses. A CT scan of the chest with IV contrast
was also performed that showed no abnormal pathology.
After this, the patient was lost to follow-up.
Discussion
Leiomyosarcomas (LMS) of the large intestines are rare
neoplasms, comprising less than 0.1% of all malignancies of
the colon and rectum.1,2 Despite this, LMS are the most
common non-epithelial gastrointestinal malignant neo-
plasms (with squamous cell carcinoma being the most com-
mon anal malignancy).1,9 The most common site for LMS is
the stomach, followed by the small intestine, then the co-
lon and rectum.4,10 Furthermore, isolated LMS of the anal
canal is exceedingly rare with only eight reported cases in
the world literature. The first reported case of LMS of the
anus in the world literature was a case by Wolfson and Oh
in 1977.7 After a thorough search of the world literature,
only seven cases followed.1,2,4e8 LMS of the gastrointestinal
tract are most commonly seen during the fifth and sixth de-
cades of life, although there are exceptions with rare cases
being reported in infants and children.4,11 The tumor may
arise from the smooth muscle of the muscularis propria,
muscularis mucosa, or blood vessels musculature. Dual leio-
myosarcomas may also develop from the arrectores pilorum
muscles of the subcutis, although the large tumor size usu-
ally prevents precise determination of site of origin. Akwari
et al. reviewed 108 cases of primary intestinal leiomyosar-
coma and reported only two arising in the anus.12 They
concluded that the main factor in determining survival was
the histologic grade, while the site and size of the primary
tumor did not affect survival rate (except when neighboring
tissues or organs were involved and not completely ex-
cised). Hematogenous metastasis most commonly to the
lungs or liver, occurred in 90% of those who die, while re-
gional lymph node metastasis were relatively uncommon,
seen in only 6% of patients.1 This was also observed by
Kiss and Menesi.13
Figure 7 The excised scar mass showed features similar to
the previously excised tumor with greater than 15 mitoses/
10 hpf, characteristic of high-grade smooth muscle malignancy
(demonstrating local recurrence of the LMS) (hematoxylin and
eosin, magnification is 40).
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treatment for LMS of the large intestine is controversial.
This fact is compounded for LMS of the anal canal.
A considerable amount of the details concerning the extent
of the disease, specific details concerning treatment,
adjuvant therapy and follow up are lacking in the in-
ternational literature, making a consensus statement of
optimal treatment difficult. Minsky et al. writes that while
the optimal treatment for anal LMS cannot be determined
due to limited patient population, management decisions
must be based on the treatment results of the more
common epithelial tumors arising in this region, such as
squamous cell carcinoma.4,9
While it would at first seem preposterous to look at
epithelial tumors to help dictate treatment for non-epithe-
lial, mesenchymal tumors, it is known that smooth muscles
tumors arising in different sites usually behave biologically
different and have more commonalties with other tumors
arising from that particular region.14 The cases that de-
scribe local resections for anal leiomyosarcoma list recur-
rences as a major complication. Diamante and Bacon list
the recurrence rate to be 86% for rectal LMS after local ex-
cision.15 The standard surgical therapy for epithelial tumors
is abdominoperineal resection (APR) because local excision
alone is associated with a 75e100% incidence of local
recurrences for lesions greater than 2.5 cm.4 Quan and Berg
report that the optimal treatment for low grade tumors and
those less than 2.5 cm in diameter was a wide local excision
followed by interstitial radiation, while those larger than
2.5 cm were best treated by early APR.16 However, Nigro
reports that external irradiation in combination with 5-fluo-
rouracil and mitomycin has a 5-year survival of 78%.17 This
rate is superior to that of APR combined with chemother-
apy, or APR combined with radiation. Residual tumor after
combined therapy and unresponsive bulky tumors are
treated by local excision18 or APR.19 Combined chemother-
apy and radiation therapy (chemoradiation therapy) may
thus negate a permanent colostomy, making it very attrac-
tive to both the patient and the physician.
Therefore, even when a radical procedure is not an
option, local excision followed by radiation therapy may be
a suitable alternative. One sequelae of this treatment
modality is the serious side effects of the high dose of
radiation needed to treat anal cancers, particularly tissue
necrosis.20 In order to overcome this problem, Papillon rec-
ommends split course megavoltage XZT followed by brachy-
therapy with iridium-192 implants.21
Patients who do relapse locally have no increase in
metastatic disease when compared with those with local
recurrence following radical surgery, and surgical salvage
remains an option.
In the case of the patient described, local excision was
chosen because the patient opted for a sphincter pre-
serving procedure. However, even after his recurrence,
there was no evidence of metastases. Therefore a radical
procedure still could have been an option. Consequently
the initial local excision did not harm the patient.
In summary, the optimal treatment for leiomyosarcoma
of the anus is not known. The gold standard surgical
treatment for resectable tumors of the anal region is APR.
In selected patients conservative surgery followed by
external beam and interstitial radiation therapy may bean alternative to radical surgery, with the goals of local
control of the disease and anal sphincter preservation. It
seems sound to presuppose that while local excision does
correlate with a greater recurrence rate, it does not
correlate with a greater mortality rate, and has the benefit
of being more easily followed for local recurrence. How-
ever, more experience and longer follow up are needed
before this approach could be recommended routinely.
Conclusions
Leiomyosarcoma of the anus is an extremely rare neoplasm
affecting a fraction of 0.1% of all patients gastrointestinal
cancers.1,2 To date there have only been eight cases re-
ported in the world literature.1,2,4e8 Due to the scarcity
of this condition and the lack of specific data in some of
the previously reported cases, the optimal treatment can
only be derived from similar conditions. At present, while
recurrence rates are higher when local excision is used
with adjuvant therapy, mortality is not increased by this
choice. With local excision, radiation, and close follow-
up, a patient may be able to be managed safely and possi-
bly avoid a more radical procedure.
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